CTLN2
MCID: CTR177
MIFTS: 37

Citrullinemia, Type Ii, Adult-Onset (CTLN2)

Categories: Genetic diseases, Liver diseases, Metabolic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Citrullinemia, Type Ii, Adult-Onset

MalaCards integrated aliases for Citrullinemia, Type Ii, Adult-Onset:

Name: Citrullinemia, Type Ii, Adult-Onset 58
Citrin Deficiency 58 25 54 76 30 6 74
Citrullinemia Type Ii 54 60 76 30 6
Ctln2 58 54 60 76 56
Adult-Onset Citrullinemia Type 2 54 60 76 74
Citrullinemia, Adult-Onset Type Ii 58 13
Adult-Onset Citrullinemia Type Ii 54 60
Citrullinemia Type 2 54 60
Adult-Onset Citrin Deficiency 60
Citrullinemia, Type Ii 41
Citrullinemia 2 76

Characteristics:

Orphanet epidemiological data:

60
citrullinemia type ii
Inheritance: Autosomal recessive; Age of onset: Adult;

OMIM:

58
Inheritance:
autosomal recessive

Miscellaneous:
some patients may be asymptomatic
mean age of diagnosis is 40 years (range 11 to 79 years)
natural aversion to carbohydrates
favoring of fat and protein
increased frequency in individuals of asian descent
1 in 19,000 in japan
1 in 50,000 in korea
1 in 17,000 in china


HPO:

33
citrullinemia, type ii, adult-onset:
Inheritance autosomal recessive inheritance


GeneReviews:

25
Penetrance There appears to be a difference in penetrance of the ctln2 phenotype related to the sex of the individual...

Classifications:



External Ids:

OMIM 58 603471
MeSH 45 D056806
ICD10 via Orphanet 35 E72.2
UMLS via Orphanet 75 C1863844
Orphanet 60 ORPHA247585
MedGen 43 C1863844

Summaries for Citrullinemia, Type Ii, Adult-Onset

NIH Rare Diseases : 54 Adult-onset citrullinemia type II is an inherited disorder that causes ammonia and other toxic substances to accumulate in the blood. The condition chiefly affects the nervous system, causing confusion, restlessness, memory loss, abnormal behaviors (such as aggression, irritability, and hyperactivity), seizures, and coma. These signs and symptoms can be life-threatening. The signs and symptoms appear during adulthood and are triggered by certain medications, infections, surgery, and alcohol intake. The features of adult-onset type II citrullinemia may also develop in people who as infants had a liver disorder called neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). In many cases, the signs and symptoms of NICCD resolve within a year. Years or even decades later, however, some of these people develop the characteristic features of adult-onset type II citrullinemia. Adult-onset citrullinemia type II is caused by mutations in the SLC25A13 gene. This condition is inherited in an autosomal recessive pattern.

MalaCards based summary : Citrullinemia, Type Ii, Adult-Onset, also known as citrin deficiency, is related to citrullinemia, classic and citrullinemia, type ii, neonatal-onset. An important gene associated with Citrullinemia, Type Ii, Adult-Onset is SLC25A13 (Solute Carrier Family 25 Member 13). Affiliated tissues include liver, brain and testes, and related phenotypes are hypertriglyceridemia and hepatic steatosis

OMIM : 58 Adult-onset type II citrullinemia is an autosomal recessive metabolic disorder characterized clinically by the sudden onset of various neuropsychologic symptoms such as disorientation, abnormal behavior, convulsions, and coma due to hyperammonemia. In some cases, rapid progression can lead to brain edema and death if liver transplantation is not possible. Some patients may present with nonalcoholic hepatic steatosis or may develop hepatic fibrosis or hepatocellular carcinoma. Patients with this disorder have a natural aversion to carbohydrates and favor protein, which is in contrast to protein aversion usually observed in patients with urea cycle defects (summary by Komatsu et al., 2008). (603471)

UniProtKB/Swiss-Prot : 76 Citrullinemia 2: A form of citrullinemia, an autosomal recessive disease characterized primarily by elevated serum and urine citrulline levels. Ammonia intoxication is another manifestation. Citrullinemia type 2 is characterized by neuropsychiatric symptoms including abnormal behaviors, loss of memory, seizures and coma. Death can result from brain edema. Onset is sudden and usually between the ages of 20 and 50 years.

GeneReviews: NBK1181

Related Diseases for Citrullinemia, Type Ii, Adult-Onset

Graphical network of the top 20 diseases related to Citrullinemia, Type Ii, Adult-Onset:



Diseases related to Citrullinemia, Type Ii, Adult-Onset

Symptoms & Phenotypes for Citrullinemia, Type Ii, Adult-Onset

Human phenotypes related to Citrullinemia, Type Ii, Adult-Onset:

33 (show all 9)
# Description HPO Frequency HPO Source Accession
1 hypertriglyceridemia 33 HP:0002155
2 hepatic steatosis 33 HP:0001397
3 elevated hepatic transaminase 33 HP:0002910
4 pancreatitis 33 HP:0001733
5 confusion 33 HP:0001289
6 coma 33 HP:0001259
7 hyperammonemia 33 HP:0001987
8 hepatocellular carcinoma 33 HP:0001402
9 cerebral edema 33 HP:0002181

Symptoms via clinical synopsis from OMIM:

58
Abdomen Liver:
hepatic steatosis
fibrosis
nonalcoholic fatty liver disease
hepatocyte ballooning

Neurologic Central Nervous System:
confusion
coma
disorientation
sudden onset of neuropsychiatric symptoms
disturbance of consciousness
more
Neoplasia:
hepatocellular carcinoma

Abdomen Pancreas:
pancreatitis

Laboratory Abnormalities:
hyperammonemia
increased serum triglycerides
abnormal liver enzymes
citrullinemia
low serum albumin
more

Clinical features from OMIM:

603471

MGI Mouse Phenotypes related to Citrullinemia, Type Ii, Adult-Onset:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 hearing/vestibular/ear MP:0005377 8.62 ASS1 SLC25A13

Drugs & Therapeutics for Citrullinemia, Type Ii, Adult-Onset

Search Clinical Trials , NIH Clinical Center for Citrullinemia, Type Ii, Adult-Onset

Genetic Tests for Citrullinemia, Type Ii, Adult-Onset

Genetic tests related to Citrullinemia, Type Ii, Adult-Onset:

# Genetic test Affiliating Genes
1 Citrin Deficiency 30
2 Citrullinemia Type Ii 30 SLC25A13

Anatomical Context for Citrullinemia, Type Ii, Adult-Onset

MalaCards organs/tissues related to Citrullinemia, Type Ii, Adult-Onset:

42
Liver, Brain, Testes

Publications for Citrullinemia, Type Ii, Adult-Onset

Articles related to Citrullinemia, Type Ii, Adult-Onset:

(show top 50) (show all 111)
# Title Authors Year
1
Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) and clinical implications. ( 30642297 )
2019
2
Growth impairment in individuals with citrin deficiency. ( 30715743 )
2019
3
Pivotal role of inter-organ aspartate metabolism for treatment of mitochondrial aspartate-glutamate carrier 2 (citrin) deficiency, based on the mouse model. ( 30862943 )
2019
4
mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency. ( 31056400 )
2019
5
A 6-Year-Old Child With Citrin Deficiency and Advanced Hepatocellular Carcinoma. ( 30591617 )
2018
6
Cholesterol Metabolism Is Enhanced in the Liver and Brain of Children With Citrin Deficiency. ( 29659898 )
2018
7
SLC25A13 c.1610_1612delinsAT mutation in an Indian patient and literature review of 79 cases of citrin deficiency for genotype-phenotype associations. ( 29787821 )
2018
8
Molecular and clinical characterization of citrin deficiency in a cohort of Chinese patients in Hong Kong. ( 30181955 )
2018
9
[Analysis of SLC25A13 gene mutations in five infants with neonatal intrahepatic cholestasis caused by citrin deficiency]. ( 29419856 )
2018
10
Bile acid profiles in neonatal intrahepatic cholestasis caused by citrin deficiency. ( 28987776 )
2017
11
Analysis of islet beta cell functions and their correlations with liver dysfunction in patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). ( 29137101 )
2017
12
Molecular diagnosis of citrin deficiency in an infant with intrahepatic cholestasis: identification of a 21.7kb gross deletion that completely silences the transcriptional and translational expression of the affected SLC25A13 allele. ( 29152073 )
2017
13
Biochemical and molecular characteristics of citrin deficiency in Korean children. ( 27829683 )
2017
14
Oral aversion to dietary sugar, ethanol and glycerol correlates with alterations in specific hepatic metabolites in a mouse model of human citrin deficiency. ( 28259708 )
2017
15
Citrin deficiency: A rare but important metabolic disorder to consider in infants with faltering growth and hyperbilirubinaemia. ( 28800193 )
2017
16
p.Val452Ile mutation of the SLC25A13 gene in a Turkish patient with citrin deficiency. ( 29376577 )
2017
17
Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency Differentiated from Biliary Atresia. ( 25988746 )
2016
18
Identification of a Large SLC25A13 Deletion via Sophisticated Molecular Analyses Using Peripheral Blood Lymphocytes in an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency (NICCD): A Clinical and Molecular Study. ( 27127784 )
2016
19
SLC25A13 cDNA cloning analysis using peripheral blood lymphocytes facilitates the identification of a large deletion mutation: Molecular diagnosis of an infant with neonatal intrahepatic cholestasis caused by citrin deficiency. ( 27779681 )
2016
20
Chronic hepatitis without hepatic steatosis caused by citrin deficiency in a child. ( 26190322 )
2016
21
Malfunction in Mitochondrial β-Oxidation Contributes to Lipid Accumulation in Hepatocyte-Like Cells Derived from Citrin Deficiency-Induced Pluripotent Stem Cells. ( 26914390 )
2016
22
Case report: An adult-onset type II citrin deficiency patient in the emergency department. ( 27347070 )
2016
23
Idiopathic eruptive macular pigmentation in a child with citrin deficiency. ( 27389718 )
2016
24
Molecular diagnosis of pediatric patients with citrin deficiency in China: SLC25A13 mutation spectrum and the geographic distribution. ( 27405544 )
2016
25
Citrin deficiency presenting as acute liver failure in an eight-month-old infant. ( 26109823 )
2015
26
An Adolescent Case of Citrin Deficiency With Severe Anorexia Mimicking Anorexia Nervosa. ( 26195537 )
2015
27
CITRIN DEFICIENCY: AN INFANT INCIDENTALLY DETECTED BY PHENYLKETONURIA SCREENING WITH A NOVEL MUTATION IN SLC25A13 GENE. ( 26852511 )
2015
28
Citrin deficiency: A treatable cause of acute psychosis in adults. ( 25947987 )
2015
29
Mechanism for increased hepatic glycerol synthesis in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse: Urine glycerol and glycerol 3-phosphate as potential diagnostic markers of human citrin deficiency. ( 25952905 )
2015
30
Phenylalanine Hydroxylase Deficiency and Citrin Deficiency in a Chinese Infant. ( 26521805 )
2015
31
Clinical, molecular and functional investigation on an infant with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). ( 24586645 )
2014
32
A novel mutation of the SLC25A13 gene in a Chinese patient with citrin deficiency detected by target next-generation sequencing. ( 24161253 )
2014
33
Screening for five prevalent mutations of SLC25A13 gene in Guangdong, China: a molecular epidemiologic survey of citrin deficiency. ( 25110155 )
2014
34
A novel citrin deficiency mutation in a cholestatic infant. ( 25187103 )
2014
35
Inspissated bile syndrome in an infant with citrin deficiency and congenital anomalies of the biliary tract and esophagus: identification and pathogenicity analysis of a novel SLC25A13 mutation with incomplete penetrance. ( 25216257 )
2014
36
First Bulgarian case of citrin deficiency caused by one novel and one recurrent mutation in the SLC25A13 gene. ( 25365849 )
2014
37
Newborn screening for citrin deficiency and carnitine uptake defect using second-tier molecular tests. ( 23394329 )
2013
38
Fatigue and quality of life in citrin deficiency during adaptation and compensation stage. ( 23453692 )
2013
39
Citrin deficiency in a Romanian child living in Spain highlights the worldwide distribution of this defect and illustrates the value of nutritional therapy. ( 23835251 )
2013
40
SLC25A13 gene analysis in citrin deficiency: sixteen novel mutations in East Asian patients, and the mutation distribution in a large pediatric cohort in China. ( 24069319 )
2013
41
Treatment with lactose (galactose)-restricted and medium-chain triglyceride-supplemented formula for neonatal intrahepatic cholestasis caused by citrin deficiency. ( 23430852 )
2012
42
Diagnosis of neonatal intrahepatic cholestasis caused by citrin deficiency using high-resolution melting analysis and a clinical scoring system. ( 22575253 )
2012
43
Multiple ovarian antral follicles in a preterm infant with neonatal intrahepatic cholestasis caused by citrin deficiency: a clinical, genetic and transcriptional analysis. ( 22710133 )
2012
44
Neonatal intrahepatic cholestasis caused by citrin deficiency: prevalence and SLC25A13 mutations among Thai infants. ( 23067347 )
2012
45
Biochemical characteristics of neonatal cholestasis induced by citrin deficiency. ( 23112554 )
2012
46
Simple and rapid genetic testing for citrin deficiency by screening 11 prevalent mutations in SLC25A13. ( 22277121 )
2012
47
A tribute to Keiko Kobayashi and her work on citrin deficiency. ( 22284267 )
2012
48
Effects of supplementation on food intake, body weight and hepatic metabolites in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse model of human citrin deficiency. ( 22921887 )
2012
49
Molecular analysis of SLC25A13 gene in human peripheral blood lymphocytes: Marked transcript diversity, and the feasibility of cDNA cloning as a diagnostic tool for citrin deficiency. ( 23022256 )
2012
50
[Utilization of high-resolution melting analysis to screen patients with neonatal intrahepatic cholestasis caused by citrin deficiency]. ( 22487826 )
2012

Variations for Citrullinemia, Type Ii, Adult-Onset

ClinVar genetic disease variations for Citrullinemia, Type Ii, Adult-Onset:

6 (show top 50) (show all 108)
# Gene Variation Type Significance SNP ID Assembly Location
1 SLC25A13 NM_014251.2(SLC25A13): c.1177+1G> A single nucleotide variant Pathogenic rs80338722 GRCh37 Chromosome 7, 95813588: 95813588
2 SLC25A13 NM_014251.2(SLC25A13): c.1177+1G> A single nucleotide variant Pathogenic rs80338722 GRCh38 Chromosome 7, 96184276: 96184276
3 SLC25A13 NM_014251.2(SLC25A13): c.1638_1660dup23 (p.Ala554Glyfs) duplication Pathogenic rs80338725 GRCh37 Chromosome 7, 95751241: 95751263
4 SLC25A13 NM_014251.2(SLC25A13): c.1638_1660dup23 (p.Ala554Glyfs) duplication Pathogenic rs80338725 GRCh38 Chromosome 7, 96121929: 96121951
5 SLC25A13 NM_014251.2(SLC25A13): c.674C> A (p.Ser225Ter) single nucleotide variant Pathogenic rs80338719 GRCh37 Chromosome 7, 95820501: 95820501
6 SLC25A13 NM_014251.2(SLC25A13): c.674C> A (p.Ser225Ter) single nucleotide variant Pathogenic rs80338719 GRCh38 Chromosome 7, 96191189: 96191189
7 SLC25A13 NM_014251.2(SLC25A13): c.1311+1G> A single nucleotide variant Pathogenic rs80338723 GRCh37 Chromosome 7, 95799356: 95799356
8 SLC25A13 NM_014251.2(SLC25A13): c.1311+1G> A single nucleotide variant Pathogenic rs80338723 GRCh38 Chromosome 7, 96170044: 96170044
9 SLC25A13 NM_014251.2(SLC25A13): c.1799dupA (p.Tyr600Terfs) duplication Pathogenic rs80338726 GRCh37 Chromosome 7, 95751009: 95751009
10 SLC25A13 NM_014251.2(SLC25A13): c.1799dupA (p.Tyr600Terfs) duplication Pathogenic rs80338726 GRCh38 Chromosome 7, 96121697: 96121697
11 SLC25A13 NM_014251.2(SLC25A13): c.1763G> A (p.Arg588Gln) single nucleotide variant Uncertain significance rs121908532 GRCh37 Chromosome 7, 95751045: 95751045
12 SLC25A13 NM_014251.2(SLC25A13): c.1763G> A (p.Arg588Gln) single nucleotide variant Uncertain significance rs121908532 GRCh38 Chromosome 7, 96121733: 96121733
13 SLC25A13 NM_014251.2(SLC25A13): c.1064G> A (p.Arg355Gln) single nucleotide variant Uncertain significance rs398122839 GRCh37 Chromosome 7, 95813702: 95813702
14 SLC25A13 NM_014251.2(SLC25A13): c.1064G> A (p.Arg355Gln) single nucleotide variant Uncertain significance rs398122839 GRCh38 Chromosome 7, 96184390: 96184390
15 SLC25A13 NM_014251.2(SLC25A13): c.2T> C (p.Met1Thr) single nucleotide variant Uncertain significance rs541276426 GRCh37 Chromosome 7, 95951267: 95951267
16 SLC25A13 NM_014251.2(SLC25A13): c.2T> C (p.Met1Thr) single nucleotide variant Uncertain significance rs541276426 GRCh38 Chromosome 7, 96321955: 96321955
17 SLC25A13 NM_014251.2(SLC25A13): c.1910T> C (p.Val637Ala) single nucleotide variant Uncertain significance rs148962110 GRCh37 Chromosome 7, 95750621: 95750621
18 SLC25A13 NM_014251.2(SLC25A13): c.1910T> C (p.Val637Ala) single nucleotide variant Uncertain significance rs148962110 GRCh38 Chromosome 7, 96121309: 96121309
19 SLC25A13 NM_014251.2(SLC25A13): c.852_855delTATG (p.Met285Profs) deletion Pathogenic rs80338720 GRCh37 Chromosome 7, 95818684: 95818687
20 SLC25A13 NM_014251.2(SLC25A13): c.852_855delTATG (p.Met285Profs) deletion Pathogenic rs80338720 GRCh38 Chromosome 7, 96189372: 96189375
21 SLC25A13 NM_014251.2(SLC25A13): c.1194A> G (p.Leu398=) single nucleotide variant Benign rs2301629 GRCh37 Chromosome 7, 95800820: 95800820
22 SLC25A13 NM_014251.2(SLC25A13): c.1194A> G (p.Leu398=) single nucleotide variant Benign rs2301629 GRCh38 Chromosome 7, 96171508: 96171508
23 SLC25A13 NM_014251.2(SLC25A13): c.328+6A> G single nucleotide variant Benign rs6957975 GRCh38 Chromosome 7, 96234796: 96234796
24 SLC25A13 NM_014251.2(SLC25A13): c.328+6A> G single nucleotide variant Benign rs6957975 GRCh37 Chromosome 7, 95864108: 95864108
25 SLC25A13 NM_014251.2(SLC25A13): c.1680C> T (p.Ser560=) single nucleotide variant Benign rs150082469 GRCh37 Chromosome 7, 95751221: 95751221
26 SLC25A13 NM_014251.2(SLC25A13): c.1680C> T (p.Ser560=) single nucleotide variant Benign rs150082469 GRCh38 Chromosome 7, 96121909: 96121909
27 SLC25A13 NM_014251.2(SLC25A13): c.*729G> A single nucleotide variant Uncertain significance rs373153995 GRCh37 Chromosome 7, 95749774: 95749774
28 SLC25A13 NM_014251.2(SLC25A13): c.*729G> A single nucleotide variant Uncertain significance rs373153995 GRCh38 Chromosome 7, 96120462: 96120462
29 SLC25A13 NM_014251.2(SLC25A13): c.*517A> G single nucleotide variant Uncertain significance rs886062523 GRCh37 Chromosome 7, 95749986: 95749986
30 SLC25A13 NM_014251.2(SLC25A13): c.*517A> G single nucleotide variant Uncertain significance rs886062523 GRCh38 Chromosome 7, 96120674: 96120674
31 SLC25A13 NM_014251.2(SLC25A13): c.*310C> T single nucleotide variant Uncertain significance rs530869704 GRCh37 Chromosome 7, 95750193: 95750193
32 SLC25A13 NM_014251.2(SLC25A13): c.*310C> T single nucleotide variant Uncertain significance rs530869704 GRCh38 Chromosome 7, 96120881: 96120881
33 SLC25A13 NM_014251.2(SLC25A13): c.*72G> A single nucleotide variant Uncertain significance rs755310327 GRCh37 Chromosome 7, 95750431: 95750431
34 SLC25A13 NM_014251.2(SLC25A13): c.*72G> A single nucleotide variant Uncertain significance rs755310327 GRCh38 Chromosome 7, 96121119: 96121119
35 SLC25A13 NM_014251.2(SLC25A13): c.1177+5G> A single nucleotide variant Uncertain significance rs886062527 GRCh38 Chromosome 7, 96184272: 96184272
36 SLC25A13 NM_014251.2(SLC25A13): c.1177+5G> A single nucleotide variant Uncertain significance rs886062527 GRCh37 Chromosome 7, 95813584: 95813584
37 SLC25A13 NM_014251.2(SLC25A13): c.1088G> T (p.Gly363Val) single nucleotide variant Uncertain significance rs35996658 GRCh38 Chromosome 7, 96184366: 96184366
38 SLC25A13 NM_014251.2(SLC25A13): c.1088G> T (p.Gly363Val) single nucleotide variant Uncertain significance rs35996658 GRCh37 Chromosome 7, 95813678: 95813678
39 SLC25A13 NM_014251.2(SLC25A13): c.421G> A (p.Glu141Lys) single nucleotide variant Uncertain significance rs1131697 GRCh38 Chromosome 7, 96208885: 96208885
40 SLC25A13 NM_014251.2(SLC25A13): c.421G> A (p.Glu141Lys) single nucleotide variant Uncertain significance rs1131697 GRCh37 Chromosome 7, 95838197: 95838197
41 SLC25A13 NM_014251.2(SLC25A13): c.-85_-83dupCCG duplication Uncertain significance rs759638459 GRCh38 Chromosome 7, 96322039: 96322041
42 SLC25A13 NM_014251.2(SLC25A13): c.-85_-83dupCCG duplication Uncertain significance rs759638459 GRCh37 Chromosome 7, 95951351: 95951353
43 SLC25A13 NM_014251.2(SLC25A13): c.-115G> T single nucleotide variant Uncertain significance rs543933601 GRCh38 Chromosome 7, 96322071: 96322071
44 SLC25A13 NM_014251.2(SLC25A13): c.-115G> T single nucleotide variant Uncertain significance rs543933601 GRCh37 Chromosome 7, 95951383: 95951383
45 SLC25A13 NM_014251.2(SLC25A13): c.-127G> A single nucleotide variant Uncertain significance rs886062532 GRCh38 Chromosome 7, 96322083: 96322083
46 SLC25A13 NM_014251.2(SLC25A13): c.-127G> A single nucleotide variant Uncertain significance rs886062532 GRCh37 Chromosome 7, 95951395: 95951395
47 SLC25A13 NM_014251.2(SLC25A13): c.*909C> G single nucleotide variant Uncertain significance rs550323481 GRCh37 Chromosome 7, 95749594: 95749594
48 SLC25A13 NM_014251.2(SLC25A13): c.*909C> G single nucleotide variant Uncertain significance rs550323481 GRCh38 Chromosome 7, 96120282: 96120282
49 SLC25A13 NM_014251.2(SLC25A13): c.*570G> A single nucleotide variant Uncertain significance rs147716687 GRCh37 Chromosome 7, 95749933: 95749933
50 SLC25A13 NM_014251.2(SLC25A13): c.*570G> A single nucleotide variant Uncertain significance rs147716687 GRCh38 Chromosome 7, 96120621: 96120621

Expression for Citrullinemia, Type Ii, Adult-Onset

Search GEO for disease gene expression data for Citrullinemia, Type Ii, Adult-Onset.

Pathways for Citrullinemia, Type Ii, Adult-Onset

GO Terms for Citrullinemia, Type Ii, Adult-Onset

Molecular functions related to Citrullinemia, Type Ii, Adult-Onset according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 8.62 ASS1 SLC25A13

Sources for Citrullinemia, Type Ii, Adult-Onset

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....